Jenny Tang

Jenny Tang is head of clinical operations at Aulos. She has over 10 years of clinical research and operations experience focusing on early phase development of immuno-oncology trials from the sponsor and investigational site perspective. Ms. Tang joined Aulos from Maverick Therapeutics (now Takeda) where she served as head of clinical operations and led efforts to advance a conditionally active bispecific molecule to a first-in-human clinical trial. Prior to that, she held various operational positions at Macrogenics and Genentech, where she supported early and late phase programs for monoclonal antibodies, small molecule inhibitors and CD-3 engaging bispecifics. She also has investigational site experience running clinical trials at University of California, San Francisco, in the Early Phase Unit and holding research positions at University of California, Los Angeles, investigating antibody drug conjugates.

Ms. Tang received a B.S. and M.S. in Microbiology, Immunology and Molecular Genetics from the University of California, Los Angeles.